"RNA Polymerase III" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A DNA-dependent RNA polymerase present in bacterial, plant, and animal cells. It functions in the nucleoplasmic structure where it transcribes DNA into RNA. It has specific requirements for cations and salt and has shown an intermediate sensitivity to alpha-amanitin in comparison to RNA polymerase I and II.
| Descriptor ID |
D012320
|
| MeSH Number(s) |
D08.811.913.696.445.735.270.775
|
| Concept/Terms |
RNA Polymerase III- RNA Polymerase III
- Polymerase III, RNA
- DNA-Dependent RNA Polymerase III
- DNA Dependent RNA Polymerase III
- RNA Polymerase C
- Polymerase C, RNA
|
Below are MeSH descriptors whose meaning is more general than "RNA Polymerase III".
Below are MeSH descriptors whose meaning is more specific than "RNA Polymerase III".
This graph shows the total number of publications written about "RNA Polymerase III" by people in this website by year, and whether "RNA Polymerase III" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2011 | 1 | 0 | 1 |
| 2017 | 4 | 2 | 6 |
| 2018 | 2 | 1 | 3 |
| 2019 | 1 | 0 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "RNA Polymerase III" by people in Profiles.
-
Elevated kynurenine levels in diffuse cutaneous and anti-RNA polymerase III positive systemic sclerosis. Clin Immunol. 2019 02; 199:18-24.
-
Defective RNA polymerase III is negatively regulated by the SUMO-Ubiquitin-Cdc48 pathway. Elife. 2018 09 07; 7.
-
Structural basis of RNA polymerase III transcription initiation. Nature. 2018 01 17; 553(7688):301-306.
-
Patterns and predictors of skin score change in early diffuse systemic sclerosis from the European Scleroderma Observational Study. Ann Rheum Dis. 2018 04; 77(4):563-570.
-
Influence of antibody profile in clinical features and prognosis in a cohort of Spanish patients with systemic sclerosis. Clin Exp Rheumatol. 2017 Sep-Oct; 35 Suppl 106(4):98-105.
-
[Cancers associated with systemic sclerosis involving anti-RNA polymerase III antibodies]. Ann Dermatol Venereol. 2018 Jan; 145(1):33-36.
-
Inborn errors in RNA polymerase III underlie severe varicella zoster virus infections. J Clin Invest. 2017 Sep 01; 127(9):3543-3556.
-
Treatment outcome in early diffuse cutaneous systemic sclerosis: the European Scleroderma Observational Study (ESOS). Ann Rheum Dis. 2017 Jul; 76(7):1207-1218.
-
Systemic sclerosis with anti-RNA polymerase III positivity following silicone breast implant rupture: possible role of B-cell depletion and implant removal in the treatment. Rheumatol Int. 2017 May; 37(5):847-851.
-
Malignancies in Patients with Anti-RNA Polymerase III Antibodies and Systemic Sclerosis: Analysis of the EULAR Scleroderma Trials and Research Cohort and Possible Recommendations for Screening. J Rheumatol. 2017 05; 44(5):639-647.